IPO Weekly Recap: Healthcare deals a mixed bag in mostly positive week

Place more than four decades of experience on your team. We use a combination of underwriter contacts, global sources and contacts at large institutional funds to provide the TRUEST picture of how an IPO is shaping up prior to its debut. We are on your team. Additionally, we provide comprehensive research to outline short and long term risks of the new companies….. A full-service firm!


 

The IPO market returned from its post-Thanksgiving holiday slumber to five deals with a mixed bag of success.

IPORecap12.8.17

DenaliTherapeutics

The strongest deal of the week was Denali Therapeutics (DNLI) which followed suit with our channel checks. Denali upsized it’s offering by 5.0mm shares (60%) and priced at the midpoint of the range, $18.00. DNLI opened with a first print of $21.55 for a gain of 19.7% at first trade.

OdonateTherapeutics

 

The other Goldman Sachs underwritten biotech deal, Odonate Therapeutics (ODT), did not pan out as well. ODT priced at the low-end of its range, $24.00, and opened $1.00 below the offering price. Odonate failed to trade above its offering price in its opening week. The other healthcare offering this week,

QuanterixLogo

Quanterix Corp (QTRX), upsized and priced at the midpoint of its $14.00-$16.00 range. QTRX opened at $16.25 and traded very well in its opening two days — printing over $18.00 on Friday for more than a 20% return.

LutherBurbank

Luther Burbank (LBC) upsized its offering and priced near the bottom of the range, $10.75. The deal performed on par to how regional bank holding company offerings have done in 2017. LBC opened with a $1.00 premium and held steady throughout its opening session.

CuroGroup

 

Curo Group Holdings (CURO) held steady in its opening week as a public company. CURO priced 6.67mm shares at the low-end of the range, $14.00, and opened with an $0.80 premium. CURO traded back near the opening price but remained above it in its first two sessions.

Looking ahead to this week…there are three deals on the schedule for the upcoming week. (Click on the image to see a preview of each deal).

NewmarkGroup Print AdialPharma

IPO Weekly Recap: Healthcare deals a mixed bag in mostly positive week
Scroll to top
error: Content is protected !!